Back to Report Store Home

Liver Cancer Therapeutics Market to 2018 - Nexavar, the Only Approved Targeted Therapy for Advanced Disease, Continues to Dominate as Other Late Stage Trials Fail

  • Published: Dec-2012
  • Report Code: GBIHC287MR
  • Report Format: pdf

Description

List of Figures

Figure 1: Liver Cancer Therapeutics Market, Top Seven Markets, Revenue Forecasts ($m), 2004–2018

Figure 2: Liver Cancer Therapeutics Market, Global, Pipeline Products, by Stage of Development, 2012

Figure 3: Liver Cancer Therapeutics Market, Global, Hepatocellular Carcinoma, Treatment Options, 2012

Figure 4: Liver Cancer Therapeutics Market, Global, Hepatocellular Carcinoma, General Treatment Algorithm

Figure 5: Liver Cancer Therapeutics Market, Global, Hepatocellular Carcinoma, Stage I and II, Treatment Algorithm

Figure 6: Liver Cancer Therapeutics Market, Global, Hepatocellular Carcinoma, Stage III and IV, Treatment Algorithm

Figure 7: Liver Cancer Therapeutics Market, Top Seven Markets, Revenue Forecasts ($m), 2004–2018

Figure 8: Liver Cancer Therapeutics Market, Top Seven Markets, Revenue Forecasts by Geography ($m), 2004–2018

Figure 9: Liver Cancer Therapeutics Market, Top Seven Markets, Annual Cost of Therapy ($), 2004–2018

Figure 10: Liver Cancer Therapeutics Market, Top Seven Markets, Treatment Usage Pattern (‘000), 2004–2018

Figure 11: Liver Cancer Therapeutics Market, Top Seven Markets, Drivers and Barriers, 2012

Figure 12: Liver Cancer Therapeutics Market, US, Revenue Forecasts ($m), 2004–2018

Figure 13: Liver Cancer Therapeutics Market, US, Annual Cost of Therapy ($), 2004–2018

Figure 14: Liver Cancer Therapeutics Market, US, Treatment Usage Pattern (‘000), 2004–2018

Figure 15: Liver Cancer Therapeutics Market, Top Five European Countries, Revenue Forecast ($m), 2004–2018

Figure 16: Liver Cancer Therapeutics Market, Top Five European Countries, Market Revenue ($m), 2004–2018

Figure 17: Liver Cancer Therapeutics Market, Top Five European Countries, Annual Cost of Therapy ($), 2004–2018

Figure 18: Liver Cancer Therapeutics Market, Top Five European Countries, Treatment Usage Pattern (‘000), 2004–2018

Figure 19: Liver Cancer Therapeutics Market, Japan, Revenue Forecast ($m), 2004–2018

Figure 20: Liver Cancer Therapeutics Market, Japan, Annual Cost of Therapy ($), 2004–2018

Figure 21: Liver Cancer Therapeutics Market, Japan, Treatment Usage Pattern (‘000), 2004–2018

Figure 22: Liver Cancer Therapeutics Market, Global, Pipeline Products, by Stage of Development, 2012

Figure 23: Liver Cancer Therapeutics Market, Global, Deals by Type of Agreement, 2007–2012

Figure 24: Liver Cancer Therapeutics Market, Global, Deals by Geography, 2007–2012

Figure 25: Liver Cancer Therapeutics Market, Global, Deals by Year, 2007–2012

Figure 26: GBI Research Market Forecasting Model

License Details
Electronic PDF copy delivered via email. Report can be used by individual purchaser only.
Single User Licence
$3500
Electronic PDF copy delivered via email. Report can be shared by unlimited users within one corporate location, e.g. a regional office.
Site Licence
$7000
Electronic PDF copy delivered via email. Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company.
Global Licence
$10500
Email to a colleague Enquire Before Buying
Prefer to speak to a team member? Call us on:
+44 161 359 5414
Or click here to contact us
Secure Payments
Cards